Inpatient Management of Type 2 Diabetes
JAMA Intern Med
.
2022 May 1;182(5):543-544.
doi: 10.1001/jamainternmed.2022.0410.
Authors
Shane Warnock
1
,
Niloofar Latifi
2
Affiliations
1
Beth Israel Deaconess Medical Center, Boston, Massachusetts.
2
Hospital Medicine, The Johns Hopkins Hospital, Baltimore, Maryland.
PMID:
35311918
DOI:
10.1001/jamainternmed.2022.0410
No abstract available
MeSH terms
Blood Glucose
Diabetes Mellitus*
Diabetes Mellitus, Type 2* / drug therapy
Hospitalization
Humans
Hypoglycemic Agents / therapeutic use
Inpatients
Substances
Blood Glucose
Hypoglycemic Agents